Bristol-Myers Squibb Balance Sheet
NYSE: BMYHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Bristol-Myers Squibb financial position
At the end of fiscal 2025, Bristol-Myers Squibb reported total assets of $90.04 billion, down 2.8% from a year earlier against total liabilities of $71.53 billion. Shareholders' equity stood at $18.47 billion, or 20.5% of assets. The company held $10.21 billion in cash and equivalents against $45.11 billion of debt, a net debt position of $34.90 billion.
The current ratio (current assets divided by current liabilities) was 1.26, meaning short-term assets cover obligations due within a year. Debt-to-equity was 2.44.
Summary generated from market data by MetaCap's automated system. Methodology
Bristol-Myers Squibb balance sheet (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 10.21B | 10.35B | 11.46B | 9.12B | 13.98B | 14.55B | 12.35B | 6.91B | 5.42B | 4.24B |
| Short-Term Investments | 464.00M | 513.00M | 816.00M | 130.00M | 2.99B | 1.28B | 3.05B | 1.85B | 1.39B | 2.11B |
| Receivables | 9.59B | 9.01B | 8.88B | 8.15B | 7.98B | 7.22B | 6.48B | 4.64B | 4.35B | 3.77B |
| Inventory | 2.69B | 2.56B | 2.66B | 2.34B | 2.10B | 2.07B | 4.29B | 1.20B | 1.17B | 1.24B |
| Total Current Assets | 29.39B | 29.78B | 31.77B | 27.27B | 33.26B | 30.19B | 29.35B | 17.72B | 14.85B | 13.70B |
| Property, Plant & Equipment | 7.54B | 7.14B | 6.65B | 6.25B | 6.05B | 5.89B | 6.25B | 5.03B | 5.00B | 4.98B |
| Goodwill | 21.75B | 21.72B | 21.17B | 21.15B | 20.50B | 20.55B | 22.49B | 6.54B | 6.86B | 6.88B |
| Intangible Assets | 19.10B | 23.31B | 27.07B | 35.86B | 42.53B | 53.24B | 63.97B | 1.09B | 1.21B | 1.39B |
| Long-Term Investments | 396.00M | 320.00M | 364.00M | 0 | 0 | 433.00M | 767.00M | 1.77B | 2.48B | 2.72B |
| Total Assets | 90.04B | 92.60B | 95.16B | 96.82B | 109.31B | 118.48B | 129.94B | 34.99B | 33.55B | 33.71B |
| Accounts Payable | 3.58B | 3.60B | 3.26B | 3.04B | 2.95B | 2.71B | 2.44B | 1.89B | 2.25B | 1.66B |
| Short-Term Debt | 2.26B | 2.05B | 3.12B | 4.26B | 4.95B | 2.34B | 3.35B | 1.70B | 987.00M | 992.00M |
| Total Current Liabilities | 23.42B | 23.77B | 22.26B | 21.89B | 21.87B | 19.08B | 18.30B | 10.65B | 9.56B | 8.84B |
| Long-Term Debt | 42.85B | 47.60B | 36.65B | 35.06B | 39.60B | 48.34B | 43.39B | 5.65B | 6.97B | 5.72B |
| Total Liabilities | 71.53B | 76.22B | 65.67B | 65.70B | 73.31B | 80.60B | 78.25B | 20.86B | 21.70B | 17.36B |
| Shareholders' Equity | 18.47B | 16.34B | 29.43B | 31.06B | 35.95B | 37.82B | 51.60B | 14.03B | 11.74B | 16.18B |
| Retained Earnings | 16.90B | 14.91B | 28.77B | 25.50B | 23.82B | 21.28B | 34.47B | 34.06B | 31.16B | 33.51B |
| Total Debt | 45.11B | 49.65B | 39.77B | 39.32B | 44.55B | 50.68B | 46.73B | 7.35B | 7.96B | 6.71B |
| Net Cash (Debt) | -34.44B | -38.79B | -27.49B | -30.07B | -27.59B | -34.84B | -31.34B | 1.41B | -1.15B | -358.00M |
This table shows 10 annual periods of Bristol-Myers Squibb's balance sheet, from FY 2025 back to FY 2016, across 19 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow BMY's reporting calendar. What is a balance sheet?